Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
Teva and Medincell Submit Drug Application for Schizophrenia Treatment
May 22 2026
NASDAQ.COM
Teva Launches Long-Acting Injectable TEV-749 for Schizophrenia
May 21 2026
Newsfilter
Mark Cuban to Join Trump for Generic Drug Announcement
May 18 2026
seekingalpha
Teva Pharmaceutical's Credit Rating Upgraded to Investment Grade
May 18 2026
Newsfilter
Teva Pharmaceuticals Transforms, Poised for Growth
May 15 2026
Fool
Teva Pharmaceutical Stock Doubles, Analysts Remain Optimistic
May 14 2026
Fool
HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis
May 08 2026
seekingalpha
Teva Pharmaceuticals to Present at BofA Healthcare Conference
May 04 2026
Newsfilter
TEVA PHARMACEUTICALS: UBS Increases Price Target from $36 to $42
May 01 2026
moomoo
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Teva Exceeds All Sustainability Bond Targets
Apr 30 2026
Newsfilter
Teva Acquires Emalex to Boost Growth Strategy
Apr 30 2026
Yahoo Finance
Blackstone's $400 Million Investment in Teva: A Strategic Bet
Apr 30 2026
Fool
Blackstone Commits $400 Million to Teva's Drug Development
Apr 30 2026
NASDAQ.COM
DBEF ETF 52-Week Price Analysis
Apr 29 2026
NASDAQ.COM
Teva Pharmaceutical Adjusts Outlook Despite Strong Q1 Performance
Apr 29 2026
seekingalpha
Show More News
